SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-21-001062
Filing Date
2021-03-25
Accepted
2021-03-25 17:15:29
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K phio_10k-123120.htm 10-K 708014
2 FORM OF RESTRICTED STOCK UNIT AWARD phio_ex1003.htm EX-10.3 32437
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 1979
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL phio_ex3101.htm EX-31.1 10842
5 CERTIFICATION phio_ex3201.htm EX-32.1 4253
6 GRAPHIC image_001.jpg GRAPHIC 39937
7 GRAPHIC image_002.jpg GRAPHIC 24152
8 GRAPHIC image_003.jpg GRAPHIC 16957
9 GRAPHIC image_004.jpg GRAPHIC 20569
  Complete submission text file 0001683168-21-001062.txt   3758647

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE phio-20201231.xml EX-101.INS 530461
11 XBRL SCHEMA FILE phio-20201231.xsd EX-101.SCH 37590
12 XBRL CALCULATION FILE phio-20201231_cal.xml EX-101.CAL 57392
13 XBRL DEFINITION FILE phio-20201231_def.xml EX-101.DEF 153465
14 XBRL LABEL FILE phio-20201231_lab.xml EX-101.LAB 317747
15 XBRL PRESENTATION FILE phio-20201231_pre.xml EX-101.PRE 255197
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 21773520
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences